← Open Payments lookup

TSHEKEDI DENNIS: Open Payments

NPI 1215015508 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,736 in 227 payments from 13 companies in 2025. Trend: 2023 $4,659 · 2024 $4,711 · 2025 $5,736

Food & beverage: $5,730Education: $5
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.52$1,349
Janssen Pharmaceuticals, Inc22$765
Luye Pharma (USA) Ltd.33$674
Vanda Pharmaceuticals Inc.26$630
Alkermes, Inc.17$472
Teva Pharmaceuticals USA, Inc.26$444
E.R. Squibb & Sons, L.L.C.15$433
Otsuka America Pharmaceutical, Inc.9$308
Axsome Therapeutics, Inc.10$268
ABBVIE INC.9$211

Products named: INGREZZA, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, FANAPT, COBENFY, AUSTEDO XR, ARISTADA, Auvelity.

Industry payments across CA — which companies pay providers there.